Recent Survival Gains in Stage IV NSCLC by Sociodemographic Strata.

ABSTRACT:

Introduction

The management of stage IV NSCLC has been transformed by recent innovations. Nevertheless, access to medical innovations varies across sociodemographic groups in the United States, which may affect the rate of outcome improvements. Our objective was to evaluate the recent real-world gains in the survival of patients with stage IV NSCLC across sociodemographic groups.

Methods

The National Cancer Database was queried for treated patients diagnosed with stage IV NSCLC between 2010 and 2020. Data was analyzed in three eras (2010-2013, 2014-2017, and 2018-2020). Two-year survival was assessed using the Kaplan-Meier method. Adjusted mortality risk was calculated using stratified Cox analysis.

Results

A total of 393,586 patients with stage IV NSCLC received trea

SUBMITTER: Ayoade OF 

PROVIDER: S-EPMC11985032 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature